Theseus Pharmaceuticals Statistics
Total Valuation
BCBA:HSY has a market cap or net worth of ARS 49.52 trillion. The enterprise value is 56.26 trillion.
Market Cap | 49.52T |
Enterprise Value | 56.26T |
Important Dates
The last earnings date was Thursday, July 31, 2025.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | May 16, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.77% |
Shares Change (QoQ) | +0.02% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 145.23M |
Valuation Ratios
The trailing PE ratio is 27.26 and the forward PE ratio is 32.59.
PE Ratio | 27.26 |
Forward PE | 32.59 |
PS Ratio | 3.69 |
PB Ratio | 9.24 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.60, with an EV/FCF ratio of 28.67.
EV / Earnings | 30.97 |
EV / Sales | 3.76 |
EV / EBITDA | 15.60 |
EV / EBIT | 19.45 |
EV / FCF | 28.67 |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 1.33.
Current Ratio | 1.53 |
Quick Ratio | 0.60 |
Debt / Equity | 1.33 |
Debt / EBITDA | 2.21 |
Debt / FCF | 3.63 |
Interest Coverage | 11.12 |
Financial Efficiency
Return on equity (ROE) is 35.89% and return on invested capital (ROIC) is 13.45%.
Return on Equity (ROE) | 35.89% |
Return on Assets (ROA) | 10.47% |
Return on Invested Capital (ROIC) | 13.45% |
Return on Capital Employed (ROCE) | 20.30% |
Revenue Per Employee | 695.46M |
Profits Per Employee | 94.19M |
Employee Count | 20,030 |
Asset Turnover | 0.87 |
Inventory Turnover | 4.10 |
Taxes
In the past 12 months, BCBA:HSY has paid 219.38 billion in taxes.
Income Tax | 219.38B |
Effective Tax Rate | 10.78% |
Stock Price Statistics
The stock price has decreased by -7.71% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -7.71% |
50-Day Moving Average | 10,294.10 |
200-Day Moving Average | 9,728.45 |
Relative Strength Index (RSI) | 62.23 |
Average Volume (20 Days) | 3,053 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 5.64 |
Income Statement
In the last 12 months, BCBA:HSY had revenue of ARS 13.41 trillion and earned 1.82 trillion in profits. Earnings per share was 8,942.75.
Revenue | 13.41T |
Gross Profit | 5.38T |
Operating Income | 2.59T |
Pretax Income | 2.04T |
Net Income | 1.82T |
EBITDA | 3.16T |
EBIT | 2.59T |
Earnings Per Share (EPS) | 8,942.75 |
Balance Sheet
The company has 1.08 trillion in cash and 7.13 trillion in debt, giving a net cash position of -6,042.09 billion.
Cash & Cash Equivalents | 1.08T |
Total Debt | 7.13T |
Net Cash | -6,042.09B |
Net Cash Per Share | n/a |
Equity (Book Value) | 5.36T |
Book Value Per Share | 26,452.19 |
Working Capital | 1.82T |
Cash Flow
In the last 12 months, operating cash flow was 2.55 trillion and capital expenditures -585.51 billion, giving a free cash flow of 1.96 trillion.
Operating Cash Flow | 2.55T |
Capital Expenditures | -585.51B |
Free Cash Flow | 1.96T |
FCF Per Share | n/a |
Margins
Gross margin is 40.12%, with operating and profit margins of 19.32% and 13.54%.
Gross Margin | 40.12% |
Operating Margin | 19.32% |
Pretax Margin | 15.18% |
Profit Margin | 13.54% |
EBITDA Margin | 23.58% |
EBIT Margin | 19.32% |
FCF Margin | 14.63% |
Dividends & Yields
This stock pays an annual dividend of 170.40, which amounts to a dividend yield of 1.46%.
Dividend Per Share | 170.40 |
Dividend Yield | 1.46% |
Dividend Growth (YoY) | 77.15% |
Years of Dividend Growth | 1 |
Payout Ratio | 70.84% |
Buyback Yield | 0.77% |
Shareholder Yield | 2.23% |
Earnings Yield | 3.67% |
FCF Yield | 3.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on November 17, 2022. It was a forward split with a ratio of 7.
Last Split Date | Nov 17, 2022 |
Split Type | Forward |
Split Ratio | 7 |
Scores
BCBA:HSY has an Altman Z-Score of 4.39 and a Piotroski F-Score of 5.
Altman Z-Score | 4.39 |
Piotroski F-Score | 5 |